- Home
- KALA vs UONEK Comparison
KALA vs UONEK Comparison
Compare KALA & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- UONEK
- Stock Information
- Founded
- KALA 2009
- UONEK 1980
- Country
- KALA United States
- UONEK United States
- Employees
- KALA N/A
- UONEK N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- UONEK Broadcasting
- Sector
- KALA Health Care
- UONEK Consumer Discretionary
- Exchange
- KALA Nasdaq
- UONEK Nasdaq
- Market Cap
- KALA 26.2M
- UONEK 31.6M
- IPO Year
- KALA 2017
- UONEK N/A
- Fundamental
- Price
- KALA $5.82
- UONEK $0.64
- Analyst Decision
- KALA Strong Buy
- UONEK
- Analyst Count
- KALA 3
- UONEK 0
- Target Price
- KALA $14.00
- UONEK N/A
- AVG Volume (30 Days)
- KALA 77.6K
- UONEK 169.6K
- Earning Date
- KALA 08-05-2025
- UONEK 08-07-2025
- Dividend Yield
- KALA N/A
- UONEK N/A
- EPS Growth
- KALA N/A
- UONEK N/A
- EPS
- KALA N/A
- UONEK N/A
- Revenue
- KALA N/A
- UONEK $437,499,000.00
- Revenue This Year
- KALA N/A
- UONEK N/A
- Revenue Next Year
- KALA N/A
- UONEK N/A
- P/E Ratio
- KALA N/A
- UONEK N/A
- Revenue Growth
- KALA N/A
- UONEK N/A
- 52 Week Low
- KALA $2.92
- UONEK $0.44
- 52 Week High
- KALA $11.20
- UONEK $1.57
- Technical
- Relative Strength Index (RSI)
- KALA 66.64
- UONEK 46.11
- Support Level
- KALA $4.36
- UONEK $0.56
- Resistance Level
- KALA $5.75
- UONEK $1.40
- Average True Range (ATR)
- KALA 0.54
- UONEK 0.12
- MACD
- KALA 0.08
- UONEK -0.01
- Stochastic Oscillator
- KALA 82.44
- UONEK 6.08
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.